Cummings Properties

 
   

Over the years Cummings Properties has developed impressive in-house expertise in leasing, designing, and constructing biotech, pharmaceutical, and medical facilities of all sorts. These facilities have ranged from emerging research laboratories, to pharmaceutical pilot plants, to cGMP medical manufacturing clean rooms. They also include hospital operating rooms and our Emerging Tech Centers.

Cummings Properties has built out and leased more than 2 million square feet of Massachusetts biotech space in its ten suburban communities, as more and more firms look especially toward the northern suburbs. A ranking of the 100 largest biotech firms in Massachusetts, by the Boston Business Journal, showed more of these firms in Cummings Properties' buildings than in any other community other than Boston or Cambridge.

Lease genomics space, proteomics space or nanotechnology space in Massachusetts from New England's most experienced provider. Tech space for lease from 300 to 50,000 square foot units. Lease Boston, Cambridge area space for fuel cell technology and all other tech space needs. The firm also participates in business and academic collaborations in Cummings Research Park. Visit this largest provider of biotech space at Biotech 2007.

Cummings Properties currently provides facilities for about 100 companies in the life-sciences field, including more than 50 physicians, surgeons and dentists. With very strong vertical integration, it can, and typically does, bring new facilities from concept to completion in half the time taken by most other providers. Many units are available in Energy Star buildings.

Mission critical requirements


Cummings Properties and many of its staff have extraordinary experience in complex buildouts for a wide variety of high tech, biotech, and meditech facilities. These facilities include everything from a 20,000 square foot surgi-center with five operating rooms, to Class 100 clean rooms and BL 1, 2, and 3 labs. Others include a radio station, a television studio for SportsChannel, and a classified "tempest room" for a major national defense contractor, as well as the backup emergency trading floor of a major stock exchange.

Cummings Properties, or its own open-shop construction affiliate, Atlantic Boston Construction, Inc., also of Woburn MA, routinely completes these projects in remarkably short order. More than anything else, the firm expedites projects like very few developers are likely to do, because so much of its work can be done "immediately" by its own 280-person, full-time staff.

Cummings Properties links its construction performance to your lease. This single source responsibility can save its clients significant project management time and guarantees your project completion date. This integrated approach similarly avoids the delays and finger-pointing that can result from traditional multi-headed construction teams. Established relationships between all facets of our design and construction teams speed communication and aid in developing trust and creative solutions.

Cummings Properties also provides for short-term, special projects to solve unanticipated needs. This hyper-track approach yields proven delivery-speed advantages, helping your firm keep pace with technology's rapid advances. While our construction speed is impressive, take advantage of Cummings Properties' wide selection of available temporary space. Office and general R&D facilities are immediately available and can be arranged for temporary occupancy. Even specialized technical facilities: our pre-built laboratory incubator facilities (Emerging Technology Centers, click here) can provide immediate access to technical lab facilities until your main facility is built.

Both Cummings Park in Woburn and Cummings Center in Beverly, MA provide easy access to Logan International Airport. Bedford's Hanscom Field is within easy reach of Cummings Park, while Beverly Airport serves Cummings Center with excellent private aircraft landing facilities. Helicopter landing areas are also readily available near each of these suburban Boston office and research parks, near Interstate 93 and Route 128.

Following are a number of excerpts from prominent high tech and biotech firms which currently lease office, research and laboratory space in Massachusetts from Cummings Properties. All of these quotes are from real estate advertisements published in The Boston Globe or Boston Business Journal.

  Aegis Semiconductor, Inc.

“We are delighted to be leasing from Cummings Properties. From simplified leasing and financing to incomparable design, construction and maintenance services, Cummings provides it all…They’re an excellent collaborator for any business.”
Matthias Wagner
CEO

Aegis Semiconductor is an emerging leader in dynamic optical components for communications, sensors and imaging applications. Based on its Active Thin FilmsTM technology platform, Aegis is the first company to deliver low-cost tunable filters that are reliable and easily manufactured using well-tested methods from the semiconductor industry.

  Anika Therapeutics, Inc.

“During our 20-plus years in West Cummings Park, our facility and service needs have changed considerably. Cummings Properties has always excelled in finding solutions to meet our requirements. We have unwavering confidence in their ability to meet our facility needs.”
Charles Sherwood, Ph.D.
President and CEO

Anika Therapeutics, Inc. (NASDAQ:ANIK) develops and manufactures therapeutic products to promote the repair, protection and healing of bone, cartilage and soft tissue. These ophthalmic and osteoarthritis products are based on a naturally occurring, biocompatible polymer that enhances joint function and protects soft tissues. New product development efforts include novel HA-formulations to reduce scar tissue formation after surgery and for cosmetic purposes. Founded in 1983, the company is headquartered in West Cummings Park, Woburn.

  Aphios Corporation

“Ten years ago, as a new start-up, Cummings provided Aphios with the space and the commitment that allowed us to build out premium biotech space including Biohazard Safety Laboratories and Good Manufacturing Facilities. Out of this space and commitment, we have been able to conduct our R&D and are now kicking-off our next exciting phase of product and technology commercialization.”

Trevor Castor, Ph.D.
President and CEO

Aphios is a biopharmaceutical company that is developing enhanced natural therapeutics for health maintenance and the treatment of human diseases with a focus on infectious diseases, cancer and quality-of-life medicines.

  BioTrove, Inc.

“Cummings Properties converted a 20,000 square foot office space to a top of the line, fully functional biotech facility in just 60 days. It was unbelievable how quickly the construction was completed. As a result, we experienced no down time as we moved into 12 Gill Street.”

Colin Brenan, Ph.D.
President and C.E.O.

BioTrove is an early stage biotech company commecializing micro and nanotechnology for applications in genomics, genetics and drug discovery. The company moved from Cambridge, MA, where it was founded by five scientists from the Department of Mechanical Engineering at M.I.T.

  CutisPharma, Inc.

“We were attracted to Cummings Center in Beverly because of reasonable rent and ample parking it provides compared to typical Boston/Cambridge leasing properties. Of a particular interest to us was the guaranteed availability of additional space for expansion.”

Indu A. Muni, Ph.D.
Chairman and CEO

CutisPharma was created to develop and commercialize value-added drug products and technologies in a niche market within the prescription compounding sector of the pharmaceutical industry. The company’s mission is to bring innovation to this sector of the industry and create an area of considerable new value.

  CytoCure LLC

“Cummings Center has provided us with everything we need to start research quickly. Our space was ready in two weeks and we have already expanded three times in nine months!”

Paul Durda
President and CEO

CytoCure, LLC is a cutting-edge biotechnology company dedicated to the discovery and development of novel immunotherapies for cancer.

  ElectroChem

“We have housed our operations in a Cummings Properties’ facility since ElectroChem’s inception over a decade ago because of its proven ability to accommodate any space or facility need that may arise. I have gotten to know many Cummings employees at this superb real estate firm and every interaction has been pleasurable.”

Radha Jalan, Ph.D.
President

ElectroChem Inc. has been a pioneer in Fuel Cell research and Fuel Cell product development. Founded in 1986, it holds many patents and a robust list of industry firsts. ElectroChem distinguished itself by being awarded a contract from NASA to work on its RLV (reusable launch vehicle) program; as well as maintaining over 500 customers in more than 70 countries.

GeneXP Biosciences

“With its impressive portfolio of related companies, Cummings Properties has created a formidable technology campus. Many of our business partners are within walking distance and we are assured a place to grow with Cummings’ unique expansion guarantee.”

Michael Cohen
President

GeneXP Biosciences is a start-up biotech company that delivers end-to-end solutions for gene expression profiling in high throughput formats. Unlike current industry formats, GeneXP produces robust tools and systems that merge Genomics and High Throughput drug screening, which make fully automated gene expression profiling feasible and affordable.

  Hamilton Thorne Biosciences, Inc.

“ The combination of Cummings Properties’ management, design, and construction services has allowed us to focus on our research and not on the building. We know we are in good hands and look forward to continuing a long relationship with Cummings.”

Meg Hamilton
CEO

Hamilton Thorne Biosciences is a DNA technology company, which develops ultra-high speed, user friendly devices and assays for the healthcare and environmental markets. The company introduced its first genetic products in 2002 and the introduction of its signature mold testing and fungi products is planned for the 4th quarter of 2003.

Inotek Pharmaceuticals Corporation

“Cummings Properties’ ability to capitalize a large amount of improvements into the lease affords start-up companies the ability and flexibility to use raised capital in other venues such as personnel.”

Andrew L. Salzman, M.D.
President and CEO

Inotek Pharmaceuticals is a multi-national biopharmaceutical firm focused on discovery research and the development of novel pharmaceutical technologies with potential applications in critical care, surgery, trauma, transplantation, and auto-immune diseases.

Lilliputian Systems, Inc.

“ As a start-up firm, we needed a small centrally located office and lab available for immediate occupancy. We also needed the option of expanding the facility. Very few real estate firms have all the in-house capabilities to provide this product, but Cummings Properties’ Emerging Technology Centers were a perfect fit.”

Aleksander Franz
Founder

Lilliputian Systems, Inc. is developing a next generation micro fuel cell system for portable electronics and wireless applications. These fuel cells can provide a significantly longer run time than traditional batteries and are environmentally friendly. The company employs a proprietary MEMS-based technology developed by the founders at the world-class Microsystems Technology Laboratories at MIT.

Meiogen Biotechnology Corporation

“For a small start-up company like mine, Cummings Properties made the leasing and build-out process as simple as possible. It’s also nice to know that when my business grows, I have space options right in my building.”

Leonard Maroun
President and CEO

Meiogen is an exceptional start-up biotech company that already has its first product in development (AntiferonTM) and a patented method for the treatment of a major disease, Down Syndrome. AntiferonTM, its novel proprietary interferon inhibitor (patent pending), is expected to provide the safest and most effective treatment yet available for large market diseases like Down Syndrome and AIDS where there is clear evidence that interferon, a protein our body produces to fight infection, plays an important causative role.

Nantero, Inc.

“Cummings has a substantial amount of experience working with fast-growing
startups like ours and can rapidly handle our needs, from space expansion to buildout.”

Greg Schmergel
President and CEO

Nantero is developing NRAM™, a high-density, nonvolatile random access memory chip, using nanotechnology. The company’s objective is to deliver a product that will replace all existing forms of memory, such as DRAM, SRAM and flash memory, with NRAM serving as universal memory.

Natural Pharmaceuticals, Inc.

“Cummings Center has attracted a mini-cluster of biotech and pharmaceutical companies which in turn has attracted a range of professional services that was very attractive to us.”

Roland R. Franke, Ph.D.
Co-Chief Executive Officer

Natural Pharmaceuticals, Inc. (NPI) produces a dependable supply of high-purity, semi-synthetic paclitaxel at competitive prices for the global market. Additionally, NPI provides customers with technical, regulatory, and analytical support.

  OmniSonics Medical Technologies, Inc.

“As we gear up for a U.S. launch of our product, we look forward to expanding our office and laboratory here with Cummings Properties. Their management is top-notch, as is the location.”

OmniSonics Medical Technologies is developing a novel medical device based on its patented OmniWave™ Technology platform. The Resolution® System uses acoustic (or ultrasonic) energy to resolve occlusions—often blood clots, plaque or calcific materials—which occur as a result of coronary artery disease,
hemodialysis procedures, deep vein thrombosis and peripheral artery disease.

Predix Pharmaceuticals, Inc.

“Cummings Properties understood that as a start-up pharmaceutical company, we needed to focus our resources on science to improve people’s lives, not on the facility. The combination of in-house services and competitive rates allowed us to reach this goal.”

Dr. Michael Kauffman, M.D., Ph.D.
CEO & President

Predix Pharmaceuticals, Inc. is a drug discovery and development company offering unique value for both today’s biotech investor and tomorrow’s medical patient. By tightly integrating our proprietary 3D computational chemistry technologies with traditional medicinal chemistry, we have created a drug discovery platform that dramatically accelerates the generation of new drugs associated with G-protein coupled receptors (GPCRs) and ion channels. The company will move its first drug into the clinic in 2004.

  Scion Pharmaceuticals, Inc.

“It is a pleasure working with Cummings Properties. Our positive interaction with their entire staff made it an easy decision for us to expand our existing facility at 200 Boston Avenue (in Medford).”

Scion Pharmaceuticals applies an innovative drug discovery strategy that integrates functional biology and chemistry and its discovery engine is enabled by its proprietary High-Throughput ElectroPhysiology (HTEP™) assay. This approach allows the Company to evaluate target function and drug activity at the earliest stages of the discovery process. Scion is initially utilizing this approach to discover drugs for the treatment of cardiovascular and central nervous system (CNS) disorders.

Soltec Ventures, Inc.

“As one of Cummings Center’s longest residents, I can truly appreciate the
tremendous restoration of the old factory. This has been reborn as the research center of the North Shore.”


Larry Evans
President

Soltec Ventures is a coalition of experienced bench chemists providing the advanced custom synthesis and specialty biochemical compound manufacture that researchers require. Their expertise is centered in proteomics, combinatorial chemistry, clinical diagnostics, and pharmaceutical intermediates.

VisEn Medical, Inc.

“In working with Cummings Properties management team, we were able to complete our design built facility within the expected timelines. We are extremely pleased with the results they delivered.”

Guy Mayer
CEO and Chairman of the Board

Founded in June of 2000, VisEn’s core technology platforms were originally developed at the Massachusetts General Hospital and Harvard Medical School. VisEn aggressively pursues key industry alliances to deepen and broaden its technology base and intellectual property platforms both internally and through additional corporate and academic licensing programs. VisEn is dedicated to developing and protecting leading technologies in molecular imaging, and launching key molecular imaging products with maximum market potential.

All of the above testimonials have been excerpted from approved promotional advertisements which have typically appeared in The Boston Globe, Boston Business Journal, and New England Real Estate Journal. Cummings Properties is pleased to support some of its many many life-science firms in this way, and is very appreciative of their many complimentary testimonials concerning their experiences with this firm.

Арендуйте офис в Соединенных Штатах Америки.

Арендуйте американский офис. Снимите в аренду помещение под офис или лабораторию в Бостоне, Mассачусeттс, США. Коммерческие помещения расположены в Бостоне и Кембридже, MA, США. Помещения под офис, научно-исследовательскую лабораторию, а также коммерческое пространство для продажи или в аренду по низким ценам находятся возле Международного Аэропорта Logаn, в Бостоне, MA, США. Звоните Джону Вайсману по телефону 001-781-932-7040.

Предлагаются 800 тыс. квадратных метров новых современных офисов, научно-исследовательских лабораторий и другого коммерческого пространства. Арендуйте помещение любого размера сегодня. Cummings Properties, 200 West Cummings Park, Woburn, MA 01801, USA.

 
Intentional spelling and typographical errors

Common "typographical" errors will include Commings [sic], Commins [sic] or Cummins [sic] Property [sic] and Propeties [sic], as well as using "WoburnMA," "CambridgeMA," "BeverlyMA" and "BostonMA." Others include running words together as in: "rentspace," "leasespace," "realestate," "officespace," "rentspace," "leaselaboratory," "leaseoffice," "findspace," "commercialproperty for lease," "leaselab space," "findoffice space," "lease officespace," "rentoffice space," "rent officespace," etc.

Cummins Property leases officespace, labspace and other comercial realestate in BostonMA, CambridgeMA, WoburnMA, and BeverlyMA. Rentspace in Boston and Cambridge areas for clinical offices, research, laboratories, etc. Commins Properties, leases lab and research space. Biology and chemistry labs available, as well as office, storage and distribution facilities. Call Cummings Property at 781-935-8000.

These typographical errors were added to make it easier for users to reach our Cummings Properties site even if they accidentally misspell our name or comments.

 

Facilities for NIH Research

Some people describe Cummings Properties as the best commercial real estate firm in New England. The firm offers fully permitted biotech buildings with existing Class 100,000, Class 10,000 and, sometimes, Class 1,000 clean rooms in MA, as well as fully permitted chemistry and biology laboratories in the Cambridge area for lease, with hazardous waste management in place. Lease quiet, Feng Shui-designed facilities for short or longer term critical trials in Massachusetts, and also for genetic biology, stem cell research and NIH work. Abundant free parking in all locations.

Lease Cambridge-area, turnkey labs for clinical research projects of National Human Genome Research Institute and other short or long-term grants funded by National Institutes of Health in MA. Boston area incubator facilities also for studies for National Eye Institute, National Institute on Aging, and the National Heart, Lung and Blood Institute. Boston-area facilities are also offered for National Gene Vector Laboratories, as well as for Islet Cell Research (ICR) and general genetic biology needs. Cummings Properties supports veterinary medical care through its long-term backing of Cummings School of Veterinary Medicine at Tufts University.

Lease easily expanded science and technology space in Cambridge, with dual redundant building systems. Technopoles for advanced technology in MA. Lease lab modules in Boston incubator building for technology innovations. Lease fully validated Massachusetts research space with emergency generators and 100 percent outside air. Large fully permitted Class 100K cleanroom, and smaller Class 10K, available for lease at Cummings Center in Beverly, MA. Ideal for pharmaceutical and medical device industries, built by Medtronic in 2000. Sub-lease nanotechnology space near Tufts and MIT at low rate.